CVS Health Corporation logo

CVS Health Corporation (CVS)

Market Open
5 Jun, 18:24
NYSE NYSE
$
96. 20
+1.39
+1.4607%
$
116.08B Market Cap
11.4 P/E Ratio
0.64% Div Yield
4.72M Volume
7.87 Eps
$ 94.82
Previous Close
Add Transaction
Day Range
94.97 96.63
Year Range
58.5 98.43
Want to track CVS and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
CVS Health May Spin-Off Insurance Business

CVS Health May Spin-Off Insurance Business

Deal Overview

Forbes | 1 year ago
CVS Health: Are Its Parts Worth More Than the Whole?

CVS Health: Are Its Parts Worth More Than the Whole?

CVS Health Co. NYSE: CVStransformed from one of the largest drug store pharmacy chains in the country to an integrated healthcare company when it acquired Aetna Health Insurance for $70 billion on November 28, 2018. The plan was to offer the full gamut of healthcare services and products and grow its Minute Clinics around the country, cashing in on primary care services.

Marketbeat | 1 year ago
Exclusive: CVS to exit core infusions services business, job cuts possible

Exclusive: CVS to exit core infusions services business, job cuts possible

CVS Health is exiting its core infusion services business and plans to either close or sell 29 related regional pharmacies in the coming months, a company spokesperson confirmed to Reuters on Friday.

Reuters | 1 year ago
CVS Health (CVS) Ascends While Market Falls: Some Facts to Note

CVS Health (CVS) Ascends While Market Falls: Some Facts to Note

CVS Health (CVS) reachead $66.85 at the closing of the latest trading day, reflecting a +1.33% change compared to its last close.

Zacks | 1 year ago
CVS Health Corporation (CVS) Is a Trending Stock: Facts to Know Before Betting on It

CVS Health Corporation (CVS) Is a Trending Stock: Facts to Know Before Betting on It

CVS Health (CVS) has received quite a bit of attention from Zacks.com users lately. Therefore, it is wise to be aware of the facts that can impact the stock's prospects.

Zacks | 1 year ago
Does This New Development Make CVS Stock a Buy or a Sell?

Does This New Development Make CVS Stock a Buy or a Sell?

Major changes could soon be coming, but will they drive the stock up?

Fool | 1 year ago
Billionaire Investor Pushes for Changes at CVS. Is Now the Time to Buy the Stock?

Billionaire Investor Pushes for Changes at CVS. Is Now the Time to Buy the Stock?

The stock could be poised for a turnaround.

Fool | 1 year ago
Why CVS Health stock could appreciate 35% from here

Why CVS Health stock could appreciate 35% from here

On October 4, 2024, TD Cowen upgraded CVS Health (NYSE: CVS) to Buy from Hold, raising its price target to $85 from $59. This represents a potential upside of 35%, driven by significant updates to CVS's Medicare Advantage (MA) business.

Invezz | 1 year ago
An Activist Investor Is Interested in CVS; We Take a Look

An Activist Investor Is Interested in CVS; We Take a Look

We also chat about Uber and its quest to become an everything app.

Fool | 1 year ago
CVS Health Stock Bounces on Company Updates

CVS Health Stock Bounces on Company Updates

Shares of CVS Health Corp (NYSE:CVS) are 3.9% higher to trade at $65.40 at last glance, after several updates for the healthcare giant.

Schaeffersresearch | 1 year ago
CVS Stock Can Gain 35% From Here, Analyst Says. Here's How.

CVS Stock Can Gain 35% From Here, Analyst Says. Here's How.

Changes in in the retail pharmacy's 2025 Medicare Advantage plan benefits should lower costs.

Barrons | 1 year ago
CVS is under pressure and considering a break up. Here's why that could be risky

CVS is under pressure and considering a break up. Here's why that could be risky

CVS has engaged advisors in a strategic review of its business, CNBC has reported Monday. One option being weighed is splitting up its retail pharmacy and insurance units.

Cnbc | 1 year ago
Loading...
Load More